1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
5 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 349.31k | 1,24% |
| Gross profit | 349.31k | 1,24% |
| Net profit | −6.42m | 20,40% |
| EBITDA | −1.52m | 67,66% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 2.43m€ |
Number of shares | 8.34m |
52-week high/low | 12,71€ - 0,28€ |
| Dividends | No |
Beta | 1,14 |
P/E ratio | −0,09 |
PEG ratio | 0,00 |
P/B ratio | −0,10 |
P/S ratio | 1,15 |
Company profile
| Name | VolitionRX Ltd |
| CEO | Cameron Reynolds |
| Employees | 57 |
Discover assets
Shareholders of VolitionRX Ltd also invest in the following assets
